Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-023651
Filing Date
2025-07-28
Accepted
2025-07-28 16:11:16
Documents
51
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20250630_10q.htm   iXBRL 10-Q 637582
2 EXHIBIT 31.1 ex_843148.htm EX-31.1 14179
3 EXHIBIT 31.2 ex_843149.htm EX-31.2 13979
4 EXHIBIT 32.1 ex_843150.htm EX-32.1 6388
5 EXHIBIT 32.2 ex_843151.htm EX-32.2 6168
  Complete submission text file 0001437749-25-023651.txt   3105605

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA govx-20250630.xsd EX-101.SCH 33634
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20250630_def.xml EX-101.DEF 207787
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20250630_lab.xml EX-101.LAB 184928
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20250630_pre.xml EX-101.PRE 230472
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20250630_cal.xml EX-101.CAL 25547
54 EXTRACTED XBRL INSTANCE DOCUMENT govx20250630_10q_htm.xml XML 347628
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 251155724
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)